Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/14/2017 08/15/2017 08/16/2017 08/17/2017 08/18/2017 Date
71.62(c) 71.22(c) 73.06(c) 72.78(c) 73.2(c) Last
864 471 539 305 752 124 1 351 350 1 234 880 Volume
+2.90% -0.56% +2.58% -0.38% +0.58% Change
More quotes
Financials ($)
Sales 2017 723 M
EBIT 2017 -57,0 M
Net income 2017 -54,1 M
Finance 2017 155 M
Yield 2017 -
Sales 2018 943 M
EBIT 2018 -3,41 M
Net income 2018 -17,3 M
Finance 2018 184 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 8,55x
EV / Sales2018 6,53x
Capitalization 6 336 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
08/17 EARNINGS REVIEW AND FREE RESEARCH RE : DexCom’s Q2 Top-line Surged 24%; Ou..
08/17 DEXCOM, INC. : Earnings Review and Free Research Report: DexCom’s Q2 Top-line Su..
08/16 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – CEO Sold 6,000 shares of St..
08/12 INSIDER TRADING ACTIVITY DEXCOM, INC : DXCM) – EVP Sold 3,244 shares of St..
08/04 J&P China Capital Management Company Cut By $3.59 Million Its Dexcom (DXCM) S..
08/02 DEXCOM : Announces Upcoming Conference Presentation
08/02 DEXCOM, INC. (NASDAQ : DXCM) reported earnings of ($0.16) per share beating Wall..
08/01 DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
08/01 DEXCOM : beats Street 2Q forecasts
08/01 DEXCOM INC : Results of Operations and Financial Condition, Change in Directors ..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second-q..
08/14 Big-name U.S. hedge funds shed healthcare stocks during the rally in second q..
07/28 Tech sector depresses European shares on busy earnings day
07/28 ESSILOR INTERNATIONAL : sticks to profitability target despite dip in sunglasses..
07/27 SMITH & NEPHEW : buoyed by double-digit emerging markets growth
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
08/18DexCom, Inc. 2017 Q2 - Results - Earnings Call Slides  
08/18DexCom, Inc. $DXCM Given Average Recommendation of “Buy” by Brokerages  
08/18Somewhat Positive Media Coverage Somewhat Unlikely to Impact DexCom $DXCM Sha.. 
08/16Piper Jaffray Companies Reiterates “Overweight” Rating for DexCom, Inc. $DXCM.. 
08/16DexCom's overweight rating reiterated at Piper Jaffray Companies. $78.00 PT. .. 
More tweets
Qtime:46
News from SeekingAlpha
08/18 DexCom, Inc. 2017 Q2 - Results - Earnings Call Slides
08/15 JOHNSON & JOHNSON : After Rising 15% This Year, What's Next?
08/09 DexCom's (DXCM) Presents at Canaccord Genuity Growth Broker Conference - (Tra..
08/02 DexCom (DXCM) Q2 2017 Results - Earnings Call Transcript
08/01 DexCom beats by $0.05, beats on revenue
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 87,5 $
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Kevin Sun Chief Financial Officer & Vice President
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.22.61%6 336
MEDTRONIC PLC17.10%113 356
BAXTER INTERNATIONAL37.28%33 166
C R BARD INC41.64%23 124
ZIMMER BIOMET HOLDINGS INC7.93%22 521
HOYA CORPORATION27.92%22 463